TERN vs WAT · $6.12B cap vs P/E 32, rev $1.65B
Terns Pharmaceuticals Inc (TERN) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported WAT revenue for 2026-07-04 was $1.65B. Net income was -$136.0M. Revenue was up 29.8% from 2026-04-04 to 2026-07-04. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
TERN currently screens at market cap $6.12B. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the TERN and WAT stock pages for the full models.
Not investment advice.